Rare diseases
Investigational molecules
Locations
79 New Oxford Street, WC1A 1DG, United Kingdom
Glaxosmithkline Research & Development Limited funds clinical research across multiple cancer settings, including solid tumours, breast cancer, prostate cancer, lung cancer, colorectal cancer, head and neck cancer, ovarian cancer, and multiple myeloma. Its studies also include advanced and relapsed or refractory disease, with interest in both tumour-directed therapy and immunotherapy combinations.
Research also extends to biomarker-defined cancers such as dMMR/MSI-H colorectal cancer and PD-L1-positive tumours, reflecting a strong focus on precision oncology and combination treatment strategies.
Glaxosmithkline Research & Development Limited runs clinical trials in conditions such as Asthma, Plasma cell myeloma, Neoplasm, Non-small cell lung cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgiumBelgiumBelgiumBelgium
FinlandFinlandBelgium
AustriaAustria
France
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
